# Rituximab for Pediatric Renal Transplant Rejection

> **NCT00697996** · PHASE2,PHASE3 · COMPLETED · sponsor: **Stanford University** · enrollment: 20 (—)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Rituximab for transplant rejection

## Key facts

- **NCT ID:** NCT00697996
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 20 (—)
- **Last updated:** 2008-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00697996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00697996, "Rituximab for Pediatric Renal Transplant Rejection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00697996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*